Montelukast API Market Research Report Information By Application (Asthma, Allergic Rhinitis, Bronchospasm, Urticaria, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 Executive Summary

1.1 Market Attractiveness Analysis 15

1.1.1 Global Montelukast API Market, By Application 15

1.1.2 Global Montelukast API Market, By Region 16

2 Market Introduction

2.1 Definition 17

2.2 Scope of the Study 17

2.3 Market Structure 17

3 Research Methodology

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 20

3.4 Market Size Estimation 21

3.5 Forecast Model 21

3.6 List of Assumptions 22

4 Market Dynamics

4.1 Introduction 23

4.2 Drivers 24

4.2.1 Increasing Incidence of Asthma 24

4.3 Restraints 25

4.3.1 Availability of Substitutes and Adverse Effects Associated with Montelukast 25

4.4 Opportunities 26

4.4.1 Opportunities Associated with the Technological Advancements 26

5 Market Factor Analysis

5.1 Supply Chain Analysis 27

5.1.1 Research and Development 27

5.1.2 Production 27

5.1.3 Distribution & Sale 28

5.1.4 Post-Sale Review 28

5.2 Porter’s Five Forces Model 28

5.2.1 Threat of New Entrants 29

5.2.2 Intensity of Rivalry 29

5.2.3 Threat of Substitutes 29

5.2.4 Bargaining Power of Suppliers 29

5.2.5 Bargaining Power of Buyers 29

5.3 Regulatory Scenario 29

5.4 Pipeline Analysis 31

5.4.1 Introduction 31

5.4.2 Montelukast 10 mg Tablet 31

5.4.3 Montelukast Chewable 5 mg Tablets 31

5.4.4 Montelukast buccal film 32

5.4.5 Montelukast 10mg 32

5.5 Pricing Evolution 33

5.6 Patent Analysis 33

5.6.1 Overview 33

6 Montelukast API Market, by Application

6.1 Introduction 35

6.2 Asthma 37

6.3 Allergic Rhinitis 38

6.4 Bronchospasm 39

6.5 Urticaria 40

6.6 Others 41

7 Global Montelukast API Market, by Region

7.1 Introduction 43

7.2 North America 46

Montelukast API Market, by Application

7.2.1 U.S. 48

Montelukast API Market, by Application

7.2.2 Canada 49

Montelukast API Market, by Application

7.3 Latin America 50

Montelukast API Market, by Application

7.4 Europe 51

Montelukast API Market, by Application

7.4.1 Spain 53

Montelukast API Market, by Application

7.4.2 France 54

Montelukast API Market, by Application

7.4.3 UK 55

Montelukast API Market, by Application

7.4.4 Germany 56

Montelukast API Market, by Application

7.4.5 Italy 57

Montelukast API Market, by Application

7.4.6 Eastern Europe 58

Montelukast API Market, by Application

7.4.7 Rest of Europe 59

Montelukast API Market, by Application

7.5 Asia-Pacific 60

Montelukast API Market, by Application

7.5.1 China 62

Montelukast API Market, by Application

7.5.2 India 63

Montelukast API Market, by Application

7.5.3 Japan 64

Montelukast API Market, by Application

7.5.4 Rest of Asia-Pacific 65

Montelukast API Market, by Application

7.6 The Middle East and Africa 66

Montelukast API Market, by Application

7.6.1 Middle East 67

Montelukast API Market, by Application

7.6.2 Africa 68

Montelukast API Market, by Application

8 Competitive Landscape

8.1 Introduction 70

8.2 Key Development Analysis 70

9 Company Profiles

9.1 Merck Sharp & Dohme Corp 72

9.1.1 Financial Overview 72

9.1.2 Products/Services Offered 73

9.1.3 Key Developments 73

9.1.4 SWOT Analysis 73

9.1.5 Key Strategies 73

9.2 Dr. Reddy’s Laboratories Ltd 74

9.2.1 Financial Overview 74

9.2.2 Products/Services Offered 75

9.2.3 Key Developments 75

9.2.4 SWOT Analysis 75

9.2.5 Key Strategies 75

9.3 Morepen Laboratories Ltd 76

9.3.1 Financial Overview 76

9.3.2 Products/Services Offered 76

9.3.3 Key Developments 77

9.3.4 SWOT Analysis 77

9.3.5 Key Strategies 77

9.4 Mylan N.V. 78

9.4.1 Financial Overview 78

9.4.2 Products/Services Offered 79

9.4.3 Key Developments 79

9.4.4 SWOT Analysis 79

9.4.5 Key Strategies 79

9.5 Teva Pharmaceutical Industries Ltd 80

9.5.1 Financial Overview 80

9.5.2 Products/Services Offered 81

9.5.3 Key Developments 81

9.5.4 SWOT Analysis 81

9.5.5 Key Strategies 81

9.6 Hikma Pharmaceuticals PLC 82

9.6.1 Financial Overview 82

9.6.2 Products/Services Offered 83

9.6.3 Key Developments 83

9.6.4 SWOT Analysis 83

9.6.5 Key Strategies 83

9.7 Glenmark 84

9.7.1 Financial Overview 84

9.7.2 Products/Services Offered 84

9.7.3 Key Developments 85

9.7.4 SWOT Analysis 85

9.7.5 Key Strategies 85

9.8 Sandoz International GmbH 86

9.8.1 Financial Overview 86

9.8.2 Products/Services Offered 87

9.8.3 Key Developments 87

9.8.4 SWOT Analysis 87

9.8.5 Key Strategies 87

9.9 Vintage Pharmaceuticals Inc 88

9.9.1 Financial Overview 88

9.9.2 Products/Services Offered 88

9.9.3 Key Developments 89

9.9.4 SWOT Analysis 89

9.9.5 Key Strategies 89

9.10 Hetero 90

9.10.1 Financial Overview 90

9.10.2 Products/Services Offered 90

9.10.3 Key Developments 90

9.10.4 SWOT Analysis 90

9.10.5 Key Strategies 90

9.11 Aurobindo Pharma 91

9.11.1 Financial Overview 91

9.11.2 Products/Services Offered 92

9.11.3 Key Developments 92

9.11.4 SWOT Analysis 92

9.11.5 Key Strategies 92

10 Conclusion

10.1 Key Findings 93

11 List of Tables

TABLE 1 LIST OF ASSUMPTIONS 22

TABLE 2 ATORVASTATIN API MARKET: PIPELINE ANALYSIS 31

TABLE 3 PRICING EVOLUTION (2020–2020), BY REGION (USD PER KG) 33

TABLE 4 PATENT ANALYSIS FOR THE GLOBAL DULOXETINE API MARKET 33

TABLE 5 GLOBAL MONTELUKAST API, BY APPLICATION, 2020–2027 (USD THOUSAND) 36

TABLE 6 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 37

TABLE 7 GLOBAL MONTELUKAST API MARKET FOR ASTHMA, BY REGION, 2020–2027 (USD THOUSAND) 37

TABLE 8 GLOBAL MONTELUKAST API MARKET FOR ASTHMA, BY REGION, 2020–2027 (TONS) 38

TABLE 9 GLOBAL MONTELUKAST APIMARKET FOR ALLERGIC RHINITIS, BY REGION, 2020–2027 (USD THOUSAND) 38

TABLE 10 GLOBAL MONTELUKAST API MARKET FOR ALLERGIC RHINITIS, BY REGION, 2020–2027 (TONS) 39

TABLE 11 GLOBAL MONTELUKAST API MARKET FOR BRONCHOSPASM, BY REGION, 2020–2027 (USD THOUSAND) 39

TABLE 12 GLOBAL MONTELUKAST APIMARKET FOR BRONCHOSPASM, BY REGION, 2020–2027 (TONS) 40

TABLE 13 GLOBAL MONTELUKAST API MARKET FOR URTICARIA, BY REGION, 2020–2027 (USD THOUSAND) 40

TABLE 14 GLOBAL MONTELUKAST APIMARKET FOR URTICARIA, BY REGION, 2020–2027 (TONS) 41

TABLE 15 GLOBAL MONTELUKAST API MARKET FOR OTHERS, BY REGION, 2020–2027 (USD THOUSAND) 41

TABLE 16 GLOBAL MONTELUKAST API MARKET FOR OTHERS, BY REGION, 2020–2027 (TONS) 42

TABLE 17 GLOBAL MONTELUKAST API MARKET, BY REGION, 2020–2027 (USD THOUSAND) 44

TABLE 18 GLOBAL MONTELUKAST API MARKET, BY REGION, 2020–2027 (TONS) 45

TABLE 19 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 45

TABLE 20 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 46

TABLE 21 NORTH AMERICA MONTELUKAST API MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 46

TABLE 22 NORTH AMERICA MONTELUKAST APIMARKET, BY COUNTRY, 2020–2027 (TONS) 46

TABLE 23 NORTH AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 47

TABLE 24 NORTH AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 47

TABLE 25 U.S. MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 48

TABLE 26 U.S. MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 48

TABLE 27 CANADA MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 49

TABLE 28 CANADA MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 49

TABLE 29 LATIN AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 50

TABLE 30 LATIN AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 50

TABLE 31 EUROPE MONTELUKAST API MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 51

TABLE 32 EUROPE MONTELUKAST API MARKET, BY COUNTRY, 2020–2027 (TONS) 51

TABLE 33 EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 52

TABLE 34 EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 52

TABLE 35 SPAIN MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 53

TABLE 36 SPAIN MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 53

TABLE 37 FRANCE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 54

TABLE 38 FRANCE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 54

TABLE 39 UK MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 55

TABLE 40 UK MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 55

TABLE 41 GERMANY MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 56

TABLE 42 GERMANY MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 56

TABLE 43 ITALY MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 57

TABLE 44 ITALY MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 57

TABLE 45 EASTERN EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 58

TABLE 46 EASTERN EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 58

TABLE 47 REST OF EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 59

TABLE 48 REST OF EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 59

TABLE 49 ASIA-PACIFIC MONTELUKAST API MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 60

TABLE 50 ASIA-PACIFIC MONTELUKAST API MARKET, BY COUNTRY, 2020–2027 (TONS) 60

TABLE 51 ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 61

TABLE 52 ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 61

TABLE 53 CHINA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 62

TABLE 54 CHINA MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 62

TABLE 55 INDIA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 63

TABLE 56 INDIA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 63

TABLE 57 JAPAN MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 64

TABLE 58 JAPAN MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 64

TABLE 59 REST OF ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 65

TABLE 60 REST OF ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 65

TABLE 61 THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY REGION, 2020–2027 (USD THOUSAND) 66

TABLE 62 THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY REGION, 2020–2027 (TONS) 66

TABLE 63 THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 66

TABLE 64 THE MIDDLE EAST AND AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 67

TABLE 65 MIDDLE EAST MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 67

TABLE 66 MIDDLE EAST MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 68

TABLE 67 AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 68

TABLE 68 AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 2020–2027 (TONS) 69

TABLE 69 KEY DEVELOPMENTS OVERVIEW 71

DATE 71

12 List of Figures

FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 GLOBAL MONTELUKAST API MARKET ANALYSIS BY REGION 16

FIGURE 3 GLOBAL MONTELUKAST API MARKET: MARKET STRUCTURE 17

FIGURE 4 RESEARCH PROCESS FOR MRFR 18

FIGURE 5 TOP-DOWN & BOTTOM-UP APPROACH 21

FIGURE 6 MARKET DYNAMICS OVERVIEW 23

FIGURE 7 DRIVERS IMPACT ANALYSIS 24

FIGURE 8 RESTRAINTS IMPACT ANALYSIS 25

FIGURE 9 SUPPLY CHAIN: GLOBAL MONTELUKAST API MARKET 27

FIGURE 10 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL MONTELUKAST API MARKET 28

FIGURE 11 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 35

FIGURE 12 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2020–2027 (TONS) 36

FIGURE 13 GLOBAL MONTELUKAST API MARKET, BY REGION, 2020 (VALUE %) 43

FIGURE 14 GLOBAL MONTELUKAST API MARKET BY REGION, 2020–2027 (TONS) 44